Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test AFB Drug Susceptibility Test: Moxifloxacin is 21 days.

What are the prerequisites for the test AFB Drug Susceptibility Test: Moxifloxacin

  • Specimen: Clinical specimen containing acid-fast bacilli (AFB)
  • Media: Recommended media for the AFB drug susceptibility test
  • Incubation: Appropriate incubation conditions for the test
  • Identification: Confirmation of AFB species
  • Drug concentration: Moxifloxacin concentration for testing

What are the measure values for the test AFB Drug Susceptibility Test: Moxifloxacin

Drug Concentration Result
Moxifloxacin 1.0 µg/mL Resistant
Moxifloxacin 2.0 µg/mL Intermediate
Moxifloxacin 4.0 µg/mL Susceptible

What does this test AFB Drug Susceptibility Test: Moxifloxacin identify?

AFB Drug Susceptibility Test: Moxifloxacin

The AFB Drug Susceptibility Test for Moxifloxacin is used to identify the susceptibility of acid-fast bacteria (AFB) to the antibiotic Moxifloxacin. This test helps determine if the bacteria causing the infection are sensitive or resistant to Moxifloxacin, allowing healthcare providers to choose the most effective treatment for the patient.

Moxifloxacin is a fluoroquinolone antibiotic that is commonly used to treat infections caused by AFB, such as tuberculosis. By conducting this test, healthcare providers can ensure that the chosen antibiotic will effectively target and kill the AFB, leading to successful treatment outcomes for the patient.

Why is this test AFB Drug Susceptibility Test: Moxifloxacin taken?

The AFB Drug Susceptibility Test for Moxifloxacin is taken to determine the effectiveness of the antibiotic moxifloxacin against acid-fast bacteria (AFB). This test is usually conducted on individuals who have been diagnosed with AFB infections such as tuberculosis or non-tuberculous mycobacterial infections. The purpose of the test is to guide healthcare providers in selecting the most appropriate and effective treatment for the specific AFB strain that the patient is infected with. Moxifloxacin is one of the antibiotics commonly used to treat AFB infections, and this test helps to ensure that the bacteria causing the infection are susceptible to the drug, allowing for better treatment outcomes.

Popular FAQs on Test

The AFB Drug Susceptibility Test: Moxifloxacin is a laboratory test used to determine the susceptibility of mycobacteria to the antibiotic moxifloxacin. This test helps in guiding the treatment of infections caused by mycobacteria, such as tuberculosis.
The AFB Drug Susceptibility Test: Moxifloxacin is typically performed using a culture-based method, where the mycobacteria are grown in a culture medium containing moxifloxacin. The growth of mycobacteria in the presence of the antibiotic is then assessed to determine their susceptibility.
The AFB Drug Susceptibility Test: Moxifloxacin is ordered when a healthcare provider suspects a mycobacterial infection, such as tuberculosis, and wants to determine the best antibiotic treatment option. It may also be ordered if a patient's infection is not responding to the initial antibiotic therapy.
Some limitations of the AFB Drug Susceptibility Test: Moxifloxacin include the time required to obtain results, the need for specialized laboratory equipment and expertise, and the possibility of false-positive or false-negative results. It is important to interpret the test results in the context of the patient's clinical presentation and other diagnostic tests.

Customer Google Rating